ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,228Medicare Part D Prescriptions Filled, Including Refills

Rank: 314 out of 5176

$806K Total Retail Price of All Prescriptions

Rank: 439 out of 5176

686 Patients Receiving at Least One Drug in Part D
88%Patients 65 Years and Older
39% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New York
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 686 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

13% of this provider’s 686 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Risky Drugs to Seniors

1% of this provider’s 11,242 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 30%.

Prescription Price

$61 was the average price of a prescription from this provider, compared to $69 among peers.

Prescriptions per Patient

19 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New York
AMLODIPINE BESYLATE 593 565 1 2
SIMVASTATIN 421 344 2 1
OMEPRAZOLE 364 278 3 3
LEVOTHYROXINE SODIUM 339 272 4 4
HYDROCODONE-ACETAMINOPHEN 314 191 S3 5 27
ATENOLOL 302 270 6 12
LISINOPRIL 282 236 7 5
LISINOPRIL-HYDROCHLOROTHIAZIDE 281 231 8 49
SERTRALINE HCL 272 220 9 30
FUROSEMIDE 253 228 10 8
METOPROLOL SUCCINATE 250 241 11 11
GABAPENTIN 237 201 12 21
LOVASTATIN 224 204 13 46
METFORMIN HCL 202 188 14 7
LOSARTAN POTASSIUM 182 180 15 14
METFORMIN HCL ER 174 167 16 57
CITALOPRAM HBR 162 148 17 31
WARFARIN SODIUM 161 124 18 13
ATORVASTATIN CALCIUM 160 155 19 9
HYDROCHLOROTHIAZIDE 154 141 20 10
METOPROLOL TARTRATE 146 145 21 6
NEXIUM 143 114 22 16
PRAVASTATIN SODIUM 131 106 23 23
LOSARTAN-HYDROCHLOROTHIAZIDE 126 107 24 35
ZOLPIDEM TARTRATE 119 80 25 17
AMLODIPINE BESYLATE-BENAZEPRIL 118 103 26 55
FLUTICASONE PROPIONATE 116 98 27 38
TRAMADOL HCL-ACETAMINOPHEN 113 99 28 116
TAMSULOSIN HCL 111 107 29 20
FINASTERIDE 104 100 30 69
TRAZODONE HCL 103 69 31 71
ALLOPURINOL 101 101 32 41
TRIAMTERENE-HCTZ 99 88 33 86
DONEPEZIL HCL 96 96 34 28
LANSOPRAZOLE 95 86 35 113
MIRTAZAPINE 93 93 36 45
AZITHROMYCIN 85 76 37 42
SPIRIVA 84 71 38 54
POLYETHYLENE GLYCOL 3350 84 75 38 74
CELEBREX 76 69 40 80
DIOVAN HCT 73 70 41 39
DETROL LA 72 52 42 249
MECLIZINE HCL 72 68 42 81
GLIPIZIDE 69 69 44 63
NYSTATIN-TRIAMCINOLONE 69 65 44 142
GLIPIZIDE ER 68 56 46 117
ALENDRONATE SODIUM 68 67 46 18
SYNTHROID 67 63 48 33
FENOFIBRATE 66 41 49 102
TRAMADOL HCL 65 35 50 40
DIGOXIN 65 55 50 56
ESCITALOPRAM OXALATE 64 54 52 89
LANTUS 62 46 53 66
CIPROFLOXACIN HCL 62 62 53 84
GLIMEPIRIDE 58 55 55 37
ISOSORBIDE MONONITRATE ER 57 57 56 44
VENTOLIN HFA 56 36 57 64
IRBESARTAN 55 50 58 215
OXYBUTYNIN CHLORIDE ER 55 29 58 204
PREDNISONE 55 45 58 52
BENAZEPRIL HCL 54 49 61 131
CRESTOR 53 43 62 15
TRIAMCINOLONE ACETONIDE 53 50 62 125
DIOVAN 53 43 62 19
IBUPROFEN 52 36 65 72
EVISTA 51 51 66 65
COMBIVENT 51 38 66 156
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 22, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.